METHOD OF SUPPRESSING UNDESIRED HAEMATOLOGICAL EFFECTS OF CHEMOTHERAPY AND/OR RADIOTHERAPY

The present invention relates to a method comprising the administration of a special pharmaceutical or dietetic preparation containing lipoic acid and/or lipoic acid analogue in an effective amount to suppress the reduction in blood cell count resulting from chemotherapy and/or radiotherapy. The inv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VAN DEN BERG, JEROEN, JOHANNES, MARIA, OSANTO, SUSANNE, HAGEMAN, ROBERT, JOHAN, JOSEPH
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a method comprising the administration of a special pharmaceutical or dietetic preparation containing lipoic acid and/or lipoic acid analogue in an effective amount to suppress the reduction in blood cell count resulting from chemotherapy and/or radiotherapy. The invention also relates to a pharmaceutical or dietetic preparation comprising : lipoic acid and/or lipoic acid analogue in an amount which is equivalent to 40-2000 mg R(+) lipoic acid; 0.2-60 umoles intact protein; 200-800 mg vitamin C; 100-500 mg vitamin D; 200-1000 mgN-acetyl cystein and 5-100 mg zinc. The present invention is concerned with a method of suppressing the detrimental effects of chemotherapy and/or radiotherapy on a patient's health. More specifically the invention relates to a method comprising the administration of a special pharmaceutical or dietetic preparation containing lipoic acid and/or lipoic acid analogue in an effective amount to suppress the reduction in blood cell count resulting from chemotherapy and/or radiotherapy. The invention also relates to a pharmaceutical or dietetic preparation comprising : lipoic acid and/or lipoic acid analogue in an amount which is equivalent to 40-2000 mg R(+) lipoic acid; 0.2-60 mu moles intact protein; 200-800 mg vitamin C; 100-500 mg vitamin D; 200-1000 mgN-acetyl cystein and 5-100 mg zinc. L'invention concerne un procédé permettant de supprimer les effets adverses de la chimiothérapie et/ou de la radiothérapie sur la santé d'un patient. L'invention concerne plus spécifiquement une méthode comprenant l'administration d'une préparation pharmaceutique ou diététique spéciale contenant de l'acide lipoïque et/ou un analogue d'acide lipoïque à raison d'une dose suffisante pour empêcher la réduction de la numération globulaire résultant d'une chimiothérapie et/ou d'une radiothérapie. L'invention concerne en outre une préparation pharmaceutique ou diététique comprenant : de l'acide lipoïque et/ou un analogue d'acide lipoïque à raison d'une quantité équivalente à 40-2000 mg d'acide lipoïque R(+), 0-60 mu moles de protéines intactes, 200-800 mg de vitamine C; 100-500 mg de vitamine D; 200-1000 mg de N-acétyl cystéine et 5-100 mg de zinc.